CIK: 1702031 - Address: 2200 Pennsylvania Avenue Nw Suite 300E, Washington, DC 20037
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
3/6/24 16:46
3/4/24
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsBirznieks GuntherDCOSVP,BusiS.m-734.210-17-5314D
3/6/23 18:24
3/2/23
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsBirznieks GuntherDCOSVP,BusiS.m-1056.230-17-8206D
3/2/22 21:26
3/1/22
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsBirznieks GuntherDCOSVP,BusiS.dm-17511.250-16-8189D
3/3/21 18:39
3/1/21
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsBirznieks GuntherDCOSVP,BusiS.m-37418.280-20-11172D
3/4/20 17:00
3/2/20
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsBirznieks GuntherDCOSVP,BusiS.m-18210.230-18-10159D
1/6/20 17:25
1/2/20
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsBirznieks GuntherDCOSVP,BusiS-6415.930-4-3147D
3/4/19 17:02
3/1/19
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsBirznieks GuntherDCOSVP,BusiS.m-25019.960-13-8151D
1/4/19 16:34
1/2/19
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsBirznieks GuntherDCOSVP,BusiS.m-16026.370-6-4134D
3/2/18 17:32
3/1/18
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsBirznieks GuntherDCOSVP,BusiS.d-16018.720-9-6140D
1/4/18 17:09
1/2/18
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsBirznieks GuntherDCOSVP,BusiS-13115.260-9-7118D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact